Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keluoxin capsule plus losartan in diabetic kidney disease
ChiCTR1900021113Phase 4Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Keluoxin and losartan in diabetic glomerulosclerosis (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Serum creatinine and Estimated glomerular filtration rate. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
Keluoxinlosartan
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR1900021113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021113.